Yıl: 2023 Cilt: 12 Sayı: 2 Sayfa Aralığı: 484 - 489 Metin Dili: İngilizce DOI: 10.5455/medscience.2023.04.050 İndeks Tarihi: 12-07-2023

Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience

Öz:
Liver cirrhosis is a progressive, irreversible disease constituted by a decrease in normal hepatocytes, diffuse fibrosis, and regeneration nodules due to liver damage developed by the chronic inflammation process. This study aims to evaluate patients with liver cirrhosis who applied to Çanakkale Onsekiz Mart University (COMU) Hospital and met the criteria in terms of demographic, etiological, and laboratory values. Patient data were recorded from the hospital data recording system that was admitted to COMU hospital between January 1, 2013, and January 01, 2022. A total of 199 patients with liver cirrhosis were included in the study. Of these patients, 38.2% were female, and 61.8% were male. Their mean age was 63.43±10.73 years. When the patients were evaluated with regard to etiological distribution, the top three etiological causes of cirrhosis were cryptogenic, alcohol-induced, and HBV in 27.6%, 27.1%, and 25.1% of patients, respectively. In terms of complications, ascites were detected in 43.2% of the patients, esophageal varices in 56.3%, splenomegaly in 69.3% and hepatic encephalopathy in 7%. Over the years, the number of patients with cirrhosis due to viral hepatitis has decreased due to an increase in viral hepatitis vaccination campaigns and the spread of antiviral treatments. However, due to the rise in chronic alcohol use, alcohol appears more frequently as a significant risk factor for the etiology of liver cirrhosis.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-51.
  • 2. Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol. 2011;25:281-90.
  • 3. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749-61.
  • 4. Yoon YH, Chen CM. Surveillance report 111: Liver cirrhosis mortality in the united states: national, state, and regional trends, 2000–2015. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, Division. 2018.
  • 5. Fialla AD, de Muckadell OBS, Touborg Lassen A. Incidence, etiology and mortality of cirrhosis: a population-based cohort study. Scand J Gastroenterol. 2012;47:702-9.
  • 6. Blachier M, Leleu H, Peck-Radosavljevic M, et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593-608.
  • 7. Bayan K, Yilmaz S, Tuzun Y, Yildirim Y. Epidemiological and clinical aspects of liver cirrhosis in adult patients living in southeastern anatolia: leading role of hbv in 505 cases. J Gastroenterol Hepatol. 2007;54:2198- 202.
  • 8. Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis. Dtsch Arztebl Int. 2013;110:85-91.
  • 9. Memik F, Dolar EJN. Günes Medical Bookstores. Liver Cirrhosis: Clinical Gastroenterology. 2005;626-33.
  • 10. Goldberg E, Chopra S. Cirrhosis in adults: etiologies, clinical manifestations and diagnosis. UpToDate. Waltham, MA. 2015.
  • 11. Sajja KC, Mohan DP, Rockey DC. Age and ethnicity in cirrhosis. J Investigative Med. 2014;62:920-6.
  • 12. Yatsuhashi H, Sano H, Hirano T, Shibasaki Y. Prognosis of patients with liver cirrhosis: a multi center retrospective observational study. Hepatol Res. 2021;51:682–93.
  • 13. Karakütük N, Etiological and demographic characteristics of patients diagnosed with liver cirrhosis in our region. ADU Faculty of Medicine, Specialization Thesis, Aydın. 2015.
  • 14. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into meld. J Gastroenterol. 2006;130:1652- 60.
  • 15. Zatoński WA, Sulkowska U, Mańczuk M, et al. Liver cirrhosis mortality in europe, with special attention to central and eastern europe. Eur Addict Res. 2010;16:193-201.
  • 16. Tozun N, Ozdogan O, Cakaloglu Y, et al. Seroprevalence of hepatitis b and c virus infections and risk factors in Turkey: a fieldwork turhep study. Clin Microbiol Infect. 2015;21:1020-6.
  • 17. Michitaka K, Nishiguchi S, Aoyagi Y, et al. Etiology of liver cirrhosis in japan: a nationwide survey. J Gastroenterol. 2009;45:86-94.
  • 18. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, et al. Etiology of liver cirrhosis in mexico. Ann Hepatol. 2004;3:30-3.
  • 19. Scaglione S, Kliethermes S, Cao G, et al. The epidemiology of cirrhosis in the united states. J Clin Gastroenterol. 2015;49:690-6.
  • 20. Ökten A. Etiology of chronic hepatitis, cirrhosis and hepatocellular carcinoma in turkey. Güncel Gastroenteroloji. 2003;7:187-91.
  • 21. Topdağı O, Etiology of the disease and frequency of complications in patients with liver cirrhosis in erzurum and its surroundings, Atatürk University Faculty of Medicine, Specialization Thesis, Erzurum. 2012.
  • 22. Yanaş G, Demographic, etiological, laboratory and prognostic evaluation of patients with liver cirrhosis admitted to Istanbul Medeniyet University Göztepe Training and Research Hospital, Specialization Thesis, İstanbul. 2020.
  • 23. Sivanathan V, Kittner J. M, Sprinzl M. F, et al. Etiology and complications of liver cirrhosis: data from a German centre. Dtsch Med Wochenschr. 2014;139:1758-62.
  • 24. James OF, Day CP. Non-alcoholic steatohepatitis (nash): a disease of emerging identity and importance. J Hepatol. 1998;29:495-501.
  • 25. Nayak NC, Vasdev N, Saigal S, Soin AS. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum Pathol. 2010;41:425-30.
  • 26. Mansour A, Watson W, Shayani V, Pickleman JJS. Abdominal operations in patients with cirrhosis: still a major surgical challenge. J Surg. 1997;122:730-6.
  • 27. Laleman W, Landeghem L, Wilmer A, et al. Portal hypertension: from pathophysiology to clinical practice. Liver Int. 2005;25:1079-90.
  • 28. Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34:81-5.
  • 29. Aydın SD, Investigation of epidemiological, laboratory and clinical data of patients with liver cirrhosis who applied to İnönü University Faculty of Medicine between 2010-2016, Inönü University Faculty of Medicine, Malatya. 2017.
  • 30. Tarao K, Nozaki A, Ikeda T, et al. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases meta analytic assessment. Cancer Med. 2019;8:1054-65.
  • 31. Demirtas CO, Gunduz F, Kani HT, et al. External validation of the toronto hepatocellular carcinoma risk index in turkish cirrhotic patients. Eur J Gastroenterol Hepatol. 2020;32:882-8.
  • 32. Frederick RT. Current concepts in the pathophysiology and management of hepatic encephalopathy. J Gastroenterol Hepatol. 2011;7:222-33.
  • 33. Grattagliano I, Ubaldi E, Bonfrate L, et al. Management of liver cirrhosis between primary care and specialists. World J Gastroenterol. 2011;17:2273.
  • 34. Wong F. Management of ascites in cirrhosis. J Gastroenterol Hepatol. 2012;27:11-20.
  • 35. Demirbaş Z. A. The use of temporal muscle thickness measured by ultrasonography in the evaluation of nutritional status in patients with liver cirrhosis, Recep Tayyip Erdoğan University Faculty of Medicine, Rize. 2021.
  • 36. Katı M O, Investigation of correlation of suPAR (Solubl-Urokinase- Typeplasminogen Activator Receptor) level with disease stage and complications in patients with liver cirrhosis, Necmettin Erbakan University Meram Medical Faculty, Konya. 2022.
APA Çelik Z, Baştürk G, Beyazit Y (2023). Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. , 484 - 489. 10.5455/medscience.2023.04.050
Chicago Çelik Zübeyir,Baştürk Gizem,Beyazit Yavuz Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. (2023): 484 - 489. 10.5455/medscience.2023.04.050
MLA Çelik Zübeyir,Baştürk Gizem,Beyazit Yavuz Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. , 2023, ss.484 - 489. 10.5455/medscience.2023.04.050
AMA Çelik Z,Baştürk G,Beyazit Y Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. . 2023; 484 - 489. 10.5455/medscience.2023.04.050
Vancouver Çelik Z,Baştürk G,Beyazit Y Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. . 2023; 484 - 489. 10.5455/medscience.2023.04.050
IEEE Çelik Z,Baştürk G,Beyazit Y "Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience." , ss.484 - 489, 2023. 10.5455/medscience.2023.04.050
ISNAD Çelik, Zübeyir vd. "Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience". (2023), 484-489. https://doi.org/10.5455/medscience.2023.04.050
APA Çelik Z, Baştürk G, Beyazit Y (2023). Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. Medicine Science, 12(2), 484 - 489. 10.5455/medscience.2023.04.050
Chicago Çelik Zübeyir,Baştürk Gizem,Beyazit Yavuz Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. Medicine Science 12, no.2 (2023): 484 - 489. 10.5455/medscience.2023.04.050
MLA Çelik Zübeyir,Baştürk Gizem,Beyazit Yavuz Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. Medicine Science, vol.12, no.2, 2023, ss.484 - 489. 10.5455/medscience.2023.04.050
AMA Çelik Z,Baştürk G,Beyazit Y Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. Medicine Science. 2023; 12(2): 484 - 489. 10.5455/medscience.2023.04.050
Vancouver Çelik Z,Baştürk G,Beyazit Y Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience. Medicine Science. 2023; 12(2): 484 - 489. 10.5455/medscience.2023.04.050
IEEE Çelik Z,Baştürk G,Beyazit Y "Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience." Medicine Science, 12, ss.484 - 489, 2023. 10.5455/medscience.2023.04.050
ISNAD Çelik, Zübeyir vd. "Retrospective Analysis of demographic and laboratory characteristics of patients with liver cirrhosis: A single center experience". Medicine Science 12/2 (2023), 484-489. https://doi.org/10.5455/medscience.2023.04.050